HC Wainwright & Co. Reiterates Buy on Vigil Neuroscience, Maintains $24 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Vigil Neuroscience (NASDAQ:VIGL) and maintained a $24 price target.
September 14, 2023 | 10:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a 'Buy' rating on Vigil Neuroscience and maintained a $24 price target.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for Vigil Neuroscience. The maintained price target of $24 indicates the firm's continued confidence in the stock's potential, which could positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100